Harvard Bioscience appoints Jeff Duchemin as the new CEO

– USA, MA –  Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its Board of Directors has hired Jeffrey A.…

Cambridge Cognition appoints Nick Kerton as CEO

UK – Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces the appointment of Nick Kerton as Chief Executive Officer of the Company and of Nick Walters as Chief Financial Officer, succeeding Ruth Keir and David Blair respectively, who have resigned from the Company.…